Chronic Spontaneous Urticaria Responds Quickly to BTK Inhibitor

(MedPage Today) -- BOSTON -- A form of chronic hives improved quickly and significantly in response to treatment with a novel Bruton's tyrosine kinase (BTK) inhibitor, a multicohort dose-finding study showed.
As many as a fourth of patients...

Source: MedPage Today Dermatology - March 31, 2022 Category: Dermatology Source Type: news